{"id":"https://openalex.org/A5143661702","orcid":null,"observed_orcids":[],"display_name":"Chang-Ping Li","raw_author_names":["Chang-Ping Li"],"full_name":"Chang-Ping Li","works_count":1,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5143661702","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I2802390878","ror":"https://ror.org/00ka6rp58","display_name":"Sir Run Run Shaw Hospital","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802390878"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4405265004","ror":"https://ror.org/03jqz2y95","display_name":"Beijing Institute for Stem Cell and Regenerative Medicine","country_code":"CN","type":"education","lineage":["https://openalex.org/I19820366","https://openalex.org/I4405265004"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I76130692","ror":"https://ror.org/00a2xv884","display_name":"Zhejiang University","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I2802390878","ror":"https://ror.org/00ka6rp58","display_name":"Sir Run Run Shaw Hospital","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802390878"]},{"id":"https://openalex.org/I4405265004","ror":"https://ror.org/03jqz2y95","display_name":"Beijing Institute for Stem Cell and Regenerative Medicine","country_code":"CN","type":"education","lineage":["https://openalex.org/I19820366","https://openalex.org/I4405265004"]},{"id":"https://openalex.org/I76130692","ror":"https://ror.org/00a2xv884","display_name":"Zhejiang University","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","count":1,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":7.6e-06,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","value":6.3e-06,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","value":3.2e-06,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","score":0.6043999791145325},{"id":"137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","score":0.5209000110626221},{"id":"113246987","wikidata":"https://www.wikidata.org/wiki/Q1534415","display_name":"Neurite","score":0.4659999907016754},{"id":"145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","score":0.32440000772476196},{"id":"10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","score":0.271699994802475}],"counts_by_year":[{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Chang-Ping Li"],"block_key":"c li","works_api_url":"https://api.openalex.org/works?filter=author.id:A5143661702","updated_date":"2026-10-28T12:34:19","created_date":"2026-07-27T00:00:00"}